Santos Marcos, Stefani Stephen, Neto Joao Paulo Reis, Santos Manoel Carlos
Faculty of Health and Sciences, University of Brasília, Brasília, Brazil.
Mae de Deus Cancer Institute, Porto Alegre, Rio Grande do Sul, Brazil.
Value Health Reg Issues. 2019 Dec;20:12-18. doi: 10.1016/j.vhri.2018.10.004. Epub 2019 Jan 8.
The congress of the International Society for Pharmacoeconomics and Outcomes Research is one of the main worldwide forums for the dissemination of research and knowledge on healthcare economics. Brazil is the largest country in Latin America, with a per-capita gross domestic product of $15 200 in 2017 and healthcare expenditure of the order of $1 318 per inhabitant. Brazilian specialists participated actively in the society's latest congress, which took place in Boston, Massachusetts, from May 20 to 24, 2017. They met to discuss the main topics dealt with at the congress and their applicability to Brazilian realities. The topics chosen were precision medicine, new challenges for economic modeling within oncology and immuno-oncology, data to aid in managerial decision making (ie, data from real-world studies), and, lastly, strategies for accessing high-cost medications in Brazil. This opinion article sought to report the main conclusions and consensus reached by this group of specialists on the occasion of this discussion.
国际药物经济学与结果研究学会大会是全球传播医疗保健经济学研究与知识的主要论坛之一。巴西是拉丁美洲最大的国家，2017年人均国内生产总值为15200美元，人均医疗保健支出约为1318美元。巴西专家积极参加了该学会于2017年5月20日至24日在马萨诸塞州波士顿举行的最新大会。他们齐聚一堂，讨论大会涉及的主要议题及其在巴西实际情况中的适用性。选定的议题包括精准医学、肿瘤学和免疫肿瘤学中经济建模的新挑战、有助于管理决策的数据（即来自真实世界研究的数据），以及最后巴西获取高成本药物的策略。这篇观点文章旨在报道这群专家在此次讨论中得出的主要结论和达成的共识。
